1. Centers for Disease Control and Prevention. HIV surveillance report, 2014; vol. 26.
http://www.cdc.gov/hiv/library/reports/surveillance/
. Published November 2015. Accessed 10 May 2016.
2. CDC. Subpopulation estimates for the HIV incidence surveillance system—United States, 2006. MMWR Morb Mortal Wkly Rep. 2008;57:985–9.
3. ACOG Committee on Obstetric Practice. ACOG Committee opinion no. 234, May 2000. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection. Int J Gynaecol Obstet. 2001;73:279–81.
4. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in Pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States.
http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf
. Accessed 20 May 2016.
5. Rakhmanina NY, van den Anker JN, Soldin SJ. Safety and pharmacokinetics of antiretroviral therapy during pregnancy. Ther Drug Monit. 2004;26:110–5.